Allspring Global Investments Holdings LLC Has $7.93 Million Stock Position in iShares Biotechnology ETF $IBB

Allspring Global Investments Holdings LLC boosted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 46,806.0% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 46,906 shares of the financial services provider’s stock after purchasing an additional 46,806 shares during the period. Allspring Global Investments Holdings LLC owned about 0.09% of iShares Biotechnology ETF worth $7,927,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of the company. Close Asset Management Ltd lifted its position in iShares Biotechnology ETF by 25.5% during the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after acquiring an additional 70 shares during the last quarter. Berger Financial Group Inc lifted its position in iShares Biotechnology ETF by 2.7% during the third quarter. Berger Financial Group Inc now owns 2,829 shares of the financial services provider’s stock worth $408,000 after acquiring an additional 75 shares during the last quarter. Kanawha Capital Management LLC lifted its position in iShares Biotechnology ETF by 0.9% during the third quarter. Kanawha Capital Management LLC now owns 8,845 shares of the financial services provider’s stock worth $1,277,000 after acquiring an additional 78 shares during the last quarter. Calton & Associates Inc. lifted its position in iShares Biotechnology ETF by 1.5% during the third quarter. Calton & Associates Inc. now owns 5,504 shares of the financial services provider’s stock worth $795,000 after acquiring an additional 81 shares during the last quarter. Finally, Private Trust Co. NA lifted its position in iShares Biotechnology ETF by 21.4% during the third quarter. Private Trust Co. NA now owns 488 shares of the financial services provider’s stock worth $70,000 after acquiring an additional 86 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $168.83 on Tuesday. The firm has a 50 day moving average price of $170.44 and a two-hundred day moving average price of $165.48. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were given a dividend of $0.1218 per share. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 annualized dividend and a yield of 0.3%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.